| ²é¿´: 1020 | »Ø¸´: 9 | ||||
clavichordгæ (СÓÐÃûÆø)
|
[ÇóÖú]
·ÒëÒ»¾ä£¬ÆäÖÐбÏß²»·Ö
|
|
1¡¢NM II activity along the airway stalks constrains airway caliber and could restrict uncontrolled migration of epithelial cells within or out of the epithelial monolayer¡£NM II likely exerts its effects on epithelia at specific sites along the developing airway, as blebbistatin increases branching before leading to airway dilation and has different effects on epithelial cells in airway stalks compared with the airway tips¡£ [ Last edited by clavichord on 2014-1-4 at 19:10 ] |
» ²ÂÄãϲ»¶
0703µ÷¼Á£¬Ò»Ö¾Ô¸Ìì½ò´óѧ319·Ö
ÒѾÓÐ7È˻ظ´
²ÄÁÏר˶(0856) 339·ÖÇóµ÷¼Á
ÒѾÓÐ9È˻ظ´
332Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
086000ÉúÎïÓëÒ½Ò©Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
081700£¬311£¬Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
308Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
316Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ13È˻ظ´
wrgeng
ר¼Ò¹ËÎÊ (Ö°Òµ×÷¼Ò)
-

ר¼Ò¾Ñé: +264 - ·ÒëEPI: 3
- Ó¦Öú: 111 (¸ßÖÐÉú)
- ¹ó±ö: 0.16
- ½ð±Ò: 24920.3
- É¢½ð: 150
- ºì»¨: 48
- Ìû×Ó: 4725
- ÔÚÏß: 630.4Сʱ
- ³æºÅ: 1227257
- ×¢²á: 2011-03-09
- ÐÔ±ð: GG
- רҵ: Äý¾Û̬ÎïÐÔI:½á¹¹¡¢Á¦Ñ§ºÍ
- ¹ÜϽ: ¾«Ï¸»¯¹¤
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
É̼ÒÒѾÖ÷¶¯ÉùÃ÷´Ë»ØÌû¿ÉÄܺ¬ÓÐÐû´«ÄÚÈÝ| NM II ÑØ×ÅÖ÷¾¥µÄÆøµÀÏÞÖÆÁËÆøµÀµÄÖ±¾¶²¢ÇÒÏÞÖÆÁËÔÚµ¥·Ö×Ó²ãÄÚÍâµÄ²»ÊÜ¿ØÖƵÄÉÏÆ¤Ï¸°ûµÄÇ¨ÒÆ¡££¬NM II ÔÚÉú³¤ÆøµÀµÄÉÏÆ¤Ï¸°ûµÄÌØ¶¨Î»ÖÃÉÏ·¢»Ó×÷ÓÃl,Èçͬblebbistatin£¨Ò»ÖÖ¿É´Ó¶à¼Ò¹«Ë¾¹ºÂòµÄÉÌÆ·»¯ÉúÎï»îÐÔ»¯ºÏÎ ÔÚÆøµÀÀ©ÕÅ֮ǰ²úÉú·ÖÖ§£¬²¢ÇÒÔÚÆøµÀµÄÖ÷¾¥ºÍÄ©¶Ë·¢»Ó²»Í¬µÄ×÷Óᣠ|
2Â¥2014-01-04 20:44:04
clavichord
гæ (СÓÐÃûÆø)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 437.6
- É¢½ð: 2
- Ìû×Ó: 203
- ÔÚÏß: 31.7Сʱ
- ³æºÅ: 2420584
- ×¢²á: 2013-04-16
- רҵ: ¼±ÖØÖ¢Ò½Ñ§/´´ÉË/ÉÕÉË/ÕûÐÎ
3Â¥2014-01-04 21:16:31
wrgeng
ר¼Ò¹ËÎÊ (Ö°Òµ×÷¼Ò)
-

ר¼Ò¾Ñé: +264 - ·ÒëEPI: 3
- Ó¦Öú: 111 (¸ßÖÐÉú)
- ¹ó±ö: 0.16
- ½ð±Ò: 24920.3
- É¢½ð: 150
- ºì»¨: 48
- Ìû×Ó: 4725
- ÔÚÏß: 630.4Сʱ
- ³æºÅ: 1227257
- ×¢²á: 2011-03-09
- ÐÔ±ð: GG
- רҵ: Äý¾Û̬ÎïÐÔI:½á¹¹¡¢Á¦Ñ§ºÍ
- ¹ÜϽ: ¾«Ï¸»¯¹¤
4Â¥2014-01-04 21:24:57
RXMCDM
°æÖ÷ (ÎÄ̳¾«Ó¢)
- ·ÒëEPI: 530
- Ó¦Öú: 401 (˶ʿ)
- ¹ó±ö: 1.908
- ½ð±Ò: 38947.6
- É¢½ð: 4908
- ºì»¨: 88
- ɳ·¢: 4
- Ìû×Ó: 11453
- ÔÚÏß: 1355.6Сʱ
- ³æºÅ: 2739168
- ×¢²á: 2013-10-20
- ÐÔ±ð: GG
- רҵ: Ò»°ã¹ÜÀíÀíÂÛÓëÑо¿·½·¨ÂÛ
- ¹ÜϽ: ÂÛÎÄ·Òë

5Â¥2014-01-04 22:39:51
clavichord
гæ (СÓÐÃûÆø)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 437.6
- É¢½ð: 2
- Ìû×Ó: 203
- ÔÚÏß: 31.7Сʱ
- ³æºÅ: 2420584
- ×¢²á: 2013-04-16
- רҵ: ¼±ÖØÖ¢Ò½Ñ§/´´ÉË/ÉÕÉË/ÕûÐÎ
6Â¥2014-01-05 10:47:01
RXMCDM
°æÖ÷ (ÎÄ̳¾«Ó¢)
- ·ÒëEPI: 530
- Ó¦Öú: 401 (˶ʿ)
- ¹ó±ö: 1.908
- ½ð±Ò: 38947.6
- É¢½ð: 4908
- ºì»¨: 88
- ɳ·¢: 4
- Ìû×Ó: 11453
- ÔÚÏß: 1355.6Сʱ
- ³æºÅ: 2739168
- ×¢²á: 2013-10-20
- ÐÔ±ð: GG
- רҵ: Ò»°ã¹ÜÀíÀíÂÛÓëÑо¿·½·¨ÂÛ
- ¹ÜϽ: ÂÛÎÄ·Òë

7Â¥2014-01-05 11:53:50
clavichord
гæ (СÓÐÃûÆø)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 437.6
- É¢½ð: 2
- Ìû×Ó: 203
- ÔÚÏß: 31.7Сʱ
- ³æºÅ: 2420584
- ×¢²á: 2013-04-16
- רҵ: ¼±ÖØÖ¢Ò½Ñ§/´´ÉË/ÉÕÉË/ÕûÐÎ
8Â¥2014-01-05 16:28:18
RXMCDM
°æÖ÷ (ÎÄ̳¾«Ó¢)
- ·ÒëEPI: 530
- Ó¦Öú: 401 (˶ʿ)
- ¹ó±ö: 1.908
- ½ð±Ò: 38947.6
- É¢½ð: 4908
- ºì»¨: 88
- ɳ·¢: 4
- Ìû×Ó: 11453
- ÔÚÏß: 1355.6Сʱ
- ³æºÅ: 2739168
- ×¢²á: 2013-10-20
- ÐÔ±ð: GG
- רҵ: Ò»°ã¹ÜÀíÀíÂÛÓëÑо¿·½·¨ÂÛ
- ¹ÜϽ: ÂÛÎÄ·Òë
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
|
Blebbistatin (¢òÐͼ¡Çòµ°°×ÒÖÖÆ¼Á,BLB£©±ðÃû:1,2,3,3a-Tetrahydro-3a-hydroxy-6-methyl-1-phenyl-4H-pyrrolo[2,3-b]quinolin-4-one; (+/-)-1-Phenyl-1,2,3,4-tetrahydro-4-hydroxypyrrolo[2,3-b]-7-methylquinolin-4-one; Blebbistatin; CAS:674289-55-5 ·Ö×Óʽ:C18H16N2O2 ·Ö×ÓÁ¿:292.33 ÉÙ´òÁË ÒÖÖÆ¼Á ÈçIIÐͼ¡Çòµ°°× Ôö¼Ó·ÖÖ§·¢ÉúÔÚµ¼ÖÂÆøµÀÀ©ÕÅǰ²¢¶ÔÖ÷ÆøµÀµÄÉÏÆ¤Ï¸°ûÓи÷ÖÖЧӦ×÷Óà |

9Â¥2014-01-05 18:23:29
clavichord
гæ (СÓÐÃûÆø)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 437.6
- É¢½ð: 2
- Ìû×Ó: 203
- ÔÚÏß: 31.7Сʱ
- ³æºÅ: 2420584
- ×¢²á: 2013-04-16
- רҵ: ¼±ÖØÖ¢Ò½Ñ§/´´ÉË/ÉÕÉË/ÕûÐÎ
10Â¥2014-01-06 10:44:37














»Ø¸´´ËÂ¥
5